TY - JOUR
AU - Martin, Christopher A.
AU - Nazareth, Joshua
AU - Jarkhi, Amar
AU - Pan, Daniel
AU - Das, Mrinal
AU - Logan, Nicola
AU - Scott, Sam
AU - Bryant, Luke
AU - Abeywickrama, Neha
AU - Adeoye, Oluwatobi
AU - Ahmed, Aleem
AU - Asif, Aqua
AU - Bandi, Srini
AU - George, Nisha
AU - Gohar, Marjan
AU - Gray, Laura J.
AU - Kaszuba, Ross
AU - Mangwani, Jitendra
AU - Martin, Marianne
AU - Moorthy, Arumugam
AU - Renals, Valerie
AU - Teece, Lucy
AU - Vail, Denny
AU - Khunti, Kamlesh
AU - Moss, Paul
AU - Tattersall, Andrea
AU - Hallis, Bassam
AU - Otter, Ashley D.
AU - Willett, Brian J.
AU - Haldar, Pranab
AU - Cooper, Andrea
AU - Pareek, Manish
AU - Rowe, Cathy
PY - 2023
DA - April
TI - Ethnic differences in cellular and humoral immune responses to SARS-CoV-2 vaccination in UK healthcare workers: a cross-sectional analysis
JO - EClinicalMedicine
VL - 58
DO - http://dx.doi.org/10.1016/j.eclinm.2023.101926
AB - Background: Few studies have compared SARS-CoV-2 vaccine immunogenicity by ethnic group. We sought to establish whether cellular and humoral immune responses to SARS-CoV-2 vaccination differ according to ethnicity in UK Healthcare workers (HCWs). Methods: In this cross-sectional analysis, we used baseline data from two immunological cohort studies conducted in HCWs in Leicester, UK. Blood samples were collected between March 3, and September 16, 2021. We excluded HCW who had not received two doses of SARS-CoV-2 vaccine at the time of sampling and those who had serological evidence of previous SARS-CoV-2 infection. Outcome measures were SARS-CoV-2 spike-specific total antibody titre, neutralising antibody titre and ELISpot count. We compared our outcome measures by ethnic group using univariable (t tests and rank-sum tests depending on distribution) and multivariable (linear regression for antibody titres and negative binomial regression for ELISpot counts) tests. Multivariable analyses were adjusted for age, sex, vaccine type, length of interval between vaccine doses and time between vaccine administration and sample collection and expressed as adjusted geometric mean ratios (aGMRs) or adjusted incidence rate ratios (aIRRs). To assess differences in the early immune response to vaccination we also conducted analyses in a subcohort who provided samples between 14 and 50 days after their second dose of vaccine. Findings: The total number of HCWs in each analysis were 401 for anti-spike antibody titres, 345 for neutralising antibody titres and 191 for ELISpot. Overall, 25.4% (19.7% South Asian and 5.7% Black/Mixed/Other) were from ethnic minority groups. In analyses including the whole cohort, neutralising antibody titres were higher in South Asian HCWs than White HCWs (aGMR 1.47, 95% CI [1.06–2.06], P = 0.02) as were T cell responses to SARS-CoV-2 S1 peptides (aIRR 1.75, 95% CI [1.05–2.89], P = 0.03). In a subcohort sampled between 14 and 50 days after second vaccine dose, SARS-CoV-2 spike-specific antibody and neutralising antibody geometric mean titre (GMT) was higher in South Asian HCWs compared to White HCWs (9616 binding antibody units (BAU)/ml, 95% CI [7178–12,852] vs 5888 BAU/ml [5023–6902], P = 0.008 and 2851 95% CI [1811–4487] vs 1199 [984–1462], P &lt; 0.001 respectively), increments which persisted after adjustment (aGMR 1.26, 95% CI [1.01–1.58], P = 0.04 and aGMR 2.01, 95% CI [1.34–3.01], P = 0.001). SARS-CoV-2 ELISpot responses to S1 and whole spike peptides (S1 + S2 response) were higher in HCWs from South Asian ethnic groups than those from White groups (S1: aIRR 2.33, 95% CI [1.09–4.94], P = 0.03; spike: aIRR, 2.04, 95% CI [1.02–4.08]). Interpretation: This study provides evidence that, in an infection naïve cohort, humoral and cellular immune responses to SARS-CoV-2 vaccination are stronger in South Asian HCWs than White HCWs. These differences are most clearly seen in the early period following vaccination. Further research is required to understand the underlying mechanisms, whether differences persist with further exposure to vaccine or virus, and the potential impact on vaccine effectiveness.
PB - Elsevier
UR - https://eprints.gla.ac.uk/296659/
KW - Coronavirus (COVID-19)
KW - Work and workforce
ER